Skip to main content
. 2016 Oct 19;11(10):e0164921. doi: 10.1371/journal.pone.0164921

Table 1. The characteristics of 139611 patients with resectable breast cancer.

ER: Estrogen receptor; HoR: Hormone receptor; PR: prognosis receptor; IDC: Infiltrating duct carcinoma; and MBC: mucinous breast cancer.

Risk Factors n (%) IDC, n (%) MBC, n (%) P *
Total 139611 136569(97.82) 3042(2.18)
Age <0.001
  Younger 115213 113163(82.86) 2050(67.39)
  Older 24398 23406(17.14) 992(32.61)
Marital status
  Married 87769 86038(63.00) 1731(56.90) <0.001
  Single 17613 17210(12.60) 403(13.25)
  Divorced 34229 33321(24.40) 908(29.85)
Race
    White 114544 112092(82.08) 2452(80.60) <0.001
    Black 12886 12656(9.27) 230(7.56)
    Other 12181 11821(8.66) 360(11.83)
Location <0.001
  Central portion of breast 11403 11051(8.09) 352(11.57)
  Upper-inner quadrant 23561 23054(16.88) 507(16.67)
  Lower-inner quadrant 12292 11844(8.67) 448(14.73)
  Upper-outer quadrant 77704 76391(55.94) 1313(43.16)
  Lower-outer quadrant 14651 14229(10.42) 422(13.87)
Differentiated grade
  Well 25570 23758(17.40) 1812(59.57) <0.001
  Moderate 57856 56792(41.58) 1064(34.98)
  Poor 56185 56019(41.02) 166(5.46)
T-classification
  T1 90953 88742(64.98) 2211(72.68)
  T2 41656 40925(29.97) 731(24.03)
  T3 4798 4709(3.45) 89(2.93) <0.001
  T4 2204 2193(1.61) 11(0.36)
N-classification
  N0 91896 89163(65.29) 2733(89.84)
  N1 33160 32908(24.10) 252(8.28)
  N2 9906 9862(7.22) 44(1.45)
  N3 4649 4636(3.39) 13(0.43) <0.001
Stage a
  I 70018 67933(49.74) 2085(68.54)
  II 52219 51349(37.60) 870(28.60)
  III 17374 17287(12.66) 87(2.86)
ER <0.001
  Negative 34915 34816(25.49) 99(3.25)
  Positive 104696 101753(74.51) 2943(96.75)
PR <0.001
  Negative 48284 47813(35.01) 471(15.48)
  Positive 91327 88756(64.99) 2571(84.52)
HoR <0.001
  Negative 31916 31829(23.31) 87(2.86)
  Positive 107695 104740(76.69) 2955(97.14)

* P values obtained from the χ2 test. All statistical tests were two-sided.